HIV vaccines--where are we going?
Heilman
C A
CA
Division of AIDS, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Baltimore
D
D
D016915:AIDS Vaccines; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D005544:Forecasting; D015483:HIV Antibodies / Q000276:immunology; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control; D000882:Haplorhini; D006801:Humans; D018449:SAIDS Vaccines; D016097:Simian Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D015302:Simian Immunodeficiency Virus / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology
D016915:AIDS Vaccines; D000911:Antibodies, Monoclonal; D015483:HIV Antibodies; D018449:SAIDS Vaccines